Supplementary Table S1

Nov 07, 2014

10 likes | 130 Vues

Supplementary Table S1. Clinicopathological features of 3 GC patients analysed on miRNA microarray.

Share Presentation

Embed Code

Link

finn-burris

Télécharger la présentation

Supplementary Table S1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

Supplementary Table S1 Clinicopathological features of 3 GC patients analysed on miRNA microarray

Supplementary Figure S1

Supplementary Figure S1. A. concentration in cell, m M. Cmpd 1. Cmpd 2. Cmpd 3. B. NADH. Cmpd IC50. 120 m M. 67 nM. 100. 60 m M. 43 nM. 30 m M. 22 nM. 75. 5 m M. 12 nM. % inhibition. 50. 25. -9. -8. -7. -6. -5. Compound 2. Supplementary Figure S2. A. 13 C.

224 views • 8 slides

Supplementary Figure S1

Supplementary Figure S1. BEX family. NXF family. TCEAL family.

116 views • 1 slides

Supplementary Figure S1

Supplementary Figure S1. A. B. C. D. E.

101 views • 1 slides

Yu et al, Supplementary Table S1 (continued)

Supplementary Fig. S1. Comparison of conserved eight RdRp motifs of FgV3 and FgV4 with the other dsRNA mycoviruses using amino acid sequences. Numbers I-VIII indicate the eight conserved motifs in RdRps of dsRNA viruses of lower eukaryotes. Ⅰ. Ⅱ. Ⅲ. Yu et al, Supplementary Table S1 (continued).

132 views • 2 slides

Supplementary Fig. S1.

Supplementary Fig. S1. Supplementary Fig. S2. Supplementary Fig. S3. Supplementary Fig. S4.

145 views • 4 slides

Supplementary Figure S1

A. Supplementary Figure S1. B. Supplementary Figure S1. C. Supplementary Figure S1. D. Supplementary Figure S1. D. A. our 5' cluster > 5ppm 32,808. GIS-RNA-PET 5' cluster > 5ppm 7,564. 6,503. B. C. GIS-RNA-PET 3' cluster > 5ppm 7,624. our 3' cluster > 5ppm 42,945.

320 views • 23 slides

Supplementary Figure S1

Supplementary Figure S1. kDa. 70. 55. FLAG monomer. 40. 35. 25. Supplementary Figure S2. kDa. 250. 130. 100. 70. 55. Supplementary Figure S3.

173 views • 3 slides

Supplementary figure S1

A. Supplementary figure S1. B. C. D. Figure S1. EGF in combination with LY294002 induces survival and NE differentiation of LNCaP cells.

162 views • 5 slides

Shiono M, et al. Supplementary Table S1

Shiono M, et al. Supplementary Table S1. Shiono M, et al. Supplementary Table S2. B. C. DAPI. WT. a. b. DAPI. WT. DAPI. NSM. DAPI. NSM. merge. Tsc1. merge. merge. Tsc1. merge. c. D. DAPI. DAPI. GSM. GSM. d. DAPI. merge. Tsc1. merge. Tsc1. f. e. DAPI. NSM. DAPI.

173 views • 6 slides

Supplementary Fig. S1

Supplementary Fig. S1. Individual Animal Data for Methylation- Sensitive Restriction Digestion, followed by Arbitrarily-Primed PCR (AP-PCR) and Capillary Eletrophoresis, for B6C3F1 and C57BL/6 Mice, 2 and 4 Week Control and 0.05% (w/w) PB Treatment Groups.

369 views • 25 slides

Supplementary Figure S1

Supplementary Figure S1. Clinical data collection, N = 336. (diagnosed by each hospital). Excluded, n = 29 (9%) Pathological sample not available. Central review of pathology, n = 307. Excluded, n = 76 (25%) 17 Malignant lymphoma, not otherwise specified

121 views • 3 slides

Supplementary Table S1

Relationship between the miRNA-21 in plasma and primary ESCC tissues. Supplementary Table S1. Relationship between the miRNA-375 in plasma and primary ESCC tissues. Supplementary Table S2. 1.0. 1.0. 0.8. 0.8. 0.6. 0.6. 0.4. 0.4. 0.2. 0.2. miR-21 AUC=0.618. miR-375 AUC=0.807. 0. 0.

106 views • 3 slides

Supplementary Fig. S1

C. 200. 160. r 2 = 0.1975 P = 0.0028. 120. Relative SMYD2 protein expression (Arbitrary unit determined by densitometer). 80. 40. 0. 0. 1. 2. 3. 4. 5. 6. Relative SMYD2 mRNA expression (/ normal esophagus). Supplementary Fig. S1. A. CENPF mRNA. 8. 6.

124 views • 1 slides

Supplementary Table S1.

Supplementary Table S1. Primer sequences used for PCR amplification of DDAH1, DDAH2 and tubulin message. Supplementary Figures. s1A. s1B. s1C. s1D.

242 views • 6 slides

Supplementary Table S1

Supplementary Table S1.

106 views • 1 slides

Supplementary Figure S1

Supplementary Figure S1. A. B. Supplementary Figure S2. Supplementary Figure S3. Supplementary Figure S4. Supplementary Figure S5. A. B. C. D. Supplementary Figure S6. A. B. LRP1B relative expression ratio. Supplementary Table S3.

292 views • 8 slides

Supplementary Fig. S1

Supplementary Fig. S1. A. B. SAS-S. SAS cisPt R. SAS-S. SAS cisPt R. G 2. G 1. Glut3(%). Glut3(%). Glut3(%). Glut3(%). G 2. G 1. G 1. G 2. G 4. G 3. CD133(%). CD133(%). mem Grp78(%). mem Grp78(%). G 1. G 2. SAS cisPt R. SAS-S. SAS cisPt R. SAS-S. G1 :

241 views • 11 slides

Supplementary Figure S1.

Supplementary Figure S1. 1 H- 15 N HSQC spectra of 15 N-labeled ZG16p titrated with Man- O - Thr (a), Man- O -peptide (b), Manα1-3Man (c) and Glc  1-3Glc (d). Marked peaks are selected for the calculation of dissociation constants (Figure 4). (a) Man- O -Thr. (b) Mannose- O -peptide.

128 views • 2 slides

Supplementary Figure S1

Supplementary Figure S1 Change of reporter activity levels after actinomycin D treatment. HEK293T cells were transiently transfected with the reporter and incubated with actinomycin D for the indicated times.

65 views • 4 slides

More Related